AlzProtect
Lille, FR · 2 known investors
Find your way into AlzProtect
87 people in our graph share verified history with the AlzProtect team — schools, employers, funds. One of them is your warm intro.
Jung Lee, PhDunlockedknows Philippe Verwaerde · together at glaxowellcome (overlapped)
×2knows the team · via Devgen
×5knows the team · via glaxowellcome
×2knows the team · via University of Lille 1 Sciences and Technology
knows the team · via Organon
knows the team · via Université catholique de Lille
Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.
Founders & leadership
PV
Philippe VerwaerdeinPresident & Chief Science OfficerPhilippe Verwaerde is President and Chief Science Officer of AlzProtect, a biotech company developing therapeutics for neurodegenerative diseases. He has held leadership roles in drug discovery across multiple therapeutic areas including inflammation, cardiovascular, anti-infectives, cancer, CNS, and metabolic diseases, with expertise spanning chemistry, biology, and translational development from preclinical through clinical phases.
Investors · 2
In the news
Frequently asked questions
- What does AlzProtect do?
- Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.
- Who founded AlzProtect?
- AlzProtect was founded by Philippe Verwaerde.
- Who are AlzProtect's investors?
- AlzProtect's investors include Xerys, Bpifrance.
- Where is AlzProtect headquartered?
- AlzProtect is headquartered in Lille, FR.